Literature DB >> 7960115

Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

G Bachrach1, M Banai, S Bardenstein, G Hoida, A Genizi, H Bercovier.   

Abstract

A delayed-type hypersensitivity (DTH) reaction in the course of brucellosis in humans and animals can be revealed by the brucellin INRA (Brucellergen) skin test. Brucellergen is composed of more than 20 proteins of different molecular weights. A 12-kDa protein eliciting DTH in Brucella melitensis Rev1-sensitized guinea pigs was found to be a significant component for the allergenic properties of Brucellergen. Sequencing of the gene encoding this protein identified it as the L7/L12 ribosomal protein. The L7/L12 gene of B. melitensis was amplified by PCR and subcloned in the Escherichia coli pQE30 plasmid. The resulting recombinant protein did not produce a DTH reaction in sensitized animals. It was used to raise specific antibodies in a rabbit. Affinity chromatography with these antibodies was used to isolate a single protein from Brucellergen and from B. melitensis cytosol preparations which produced a DTH reaction in guinea pigs sensitized with B. melitensis Rev1. N-terminal amino acid sequencing of the protein confirmed that it was the L7/L12 ribosomal protein. This is the first complete report on the involvement of a defined bacterial ribosomal protein in the DTH response of animals infected with intracellularly multiplying bacteria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7960115      PMCID: PMC303276          DOI: 10.1128/iai.62.12.5361-5366.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Characterization of allergens prepared from smooth and rough strains of Brucella melitensis.

Authors:  L M Jones; R Diaz; A G Taylor
Journal:  Br J Exp Pathol       Date:  1973-10

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Immunological properties of ribosomal proteins from Mycobacterium bovis BCG.

Authors:  S Tantimavanich; S Nagai; H Nomaguchi; M Kinomoto; N Ohara; T Yamada
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

4.  Sequences of the rplJL operon containing the L10 and L7/L12 genes from Brucella abortus.

Authors:  S C Oliveira; Y Zhu; G Splitter
Journal:  Gene       Date:  1994-03-11       Impact factor: 3.688

5.  Delayed hypersensitivity to ribosomal protein from BCG.

Authors:  L Ortiz-Ortiz; E B Solarolo; L F Bojalil
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

Review 6.  Recent progress in the diagnosis of brucellosis.

Authors:  B W Stemshorn
Journal:  Dev Biol Stand       Date:  1984

7.  A comparison of five serological tests for bovine brucellosis.

Authors:  I R Dohoo; P F Wright; G M Ruckerbauer; B S Samagh; F J Robertson; L B Forbes
Journal:  Can J Vet Res       Date:  1986-10       Impact factor: 1.310

8.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

9.  Ribosomes of acid-fast bacilli: immunogenicity, serology, and in vitro correlates of delayed hypersensitivity.

Authors:  R E Baker; W E Hill; C L Larson
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

10.  Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis.

Authors:  D W Thomas; E Weiss
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

View more
  9 in total

1.  The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes.

Authors:  M Soto; C Alonso; J M Requena
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Cloning, nucleotide sequence, and expression of the gene coding for a ribosome releasing factor-homologous protein of Brucella melitensis.

Authors:  N Vizcaíno; A Cloeckaert; G Dubray; M S Zygmunt
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle.

Authors:  P A Denoel; T K Vo; A Tibor; V E Weynants; J M Trunde; G Dubray; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Delayed-type hypersensitivity activity of the Brucella L7/L12 ribosomal protein depends on posttranslational modification.

Authors:  G Bachrach; M Banai; Y Fishman; H Bercovier
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.

Authors:  Purushottam Kaushik; Dhirendra K Singh; S Vinoth Kumar; Ashok K Tiwari; Gunjan Shukla; Shanker Dayal; Pallav Chaudhuri
Journal:  Vet Res Commun       Date:  2009-12-16       Impact factor: 2.459

Review 6.  Brucellosis: an overview.

Authors:  M J Corbel
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

7.  The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection.

Authors:  Avi-Hai Hovav; Jacob Mullerad; Liuba Davidovitch; Yolanta Fishman; Fabiana Bigi; Angel Cataldi; Herve Bercovier
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis.

Authors:  Michal Gutner; Stella Chaushu; Daniela Balter; Gilad Bachrach
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

9.  In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens.

Authors:  Maryam Golshani; Melina Ghasemian; Nematollah Gheibi; Saeid Bouzari
Journal:  Adv Biomed Res       Date:  2018-02-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.